Roche collaborates with Kilele Health Association- a non-profit organization – amongst other private sector companies on a campaign to drive awareness and advocacy on Cervical Cancer prevention.
The campaign seeks to support government efforts towards their 90-70-90 cancer elimination goals by reaching 4 million women and girls by 2027 in Kenya.
Cervical Cancer affects many Kenyan women, but can be prevented with awareness and early detection.
During the event, Benda Kithaka the Executive Director for Kilele Health Association noted that GLOBOCAN Report 2020 indicates that 15 women are diagnosed with cervical cancer each day in Kenya; and 9 women die daily1.
These are women at their prime, active contributors to the economy, a glue to households, businesses and communities.
“It is our duty to save their lives and working with private sector companies like Roche and other private sector organisations can help us drive significant change,” said Madam Benda.
The collaboration will actively conduct awareness campaigns to empower women and girls to make informed decisions about their cervical health, engage in policy carry out community outreach, vaccination, and screening activations across the country.
“Access to screening and reliable HPV testing is critical to ending cervical cancer, no woman should have to die of a disease that is preventable. We are pleased to work with the Kelele Health Association to drive access and advocacy where it is needed the most”, Ida Mbuthia, Healthcare Access Lead, Roche Diagnostics.
Promoting awareness about cervical health for women and girls through education, advocacy, community outreach initiatives can help reduce inequalities in access to HPV vaccination and screening.
By working together in partnership with the government and private sector, we can take significant strides towards a future generation free from cervical cancer.
Subscribe to our YouTube channel: Switch TV
